Page last updated: 2024-11-05

xylazine and Retinal Diseases

xylazine has been researched along with Retinal Diseases in 2 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Retinal Diseases: Diseases involving the RETINA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, BA1
Bonilha, VL1
Hagstrom, SA1
Anand-Apte, B1
Hollyfield, JG1
Samuels, IS1
Kommonen, B1
Raitta, C1

Other Studies

2 other studies available for xylazine and Retinal Diseases

ArticleYear
Prolonged ocular exposure leads to retinal lesions in mice.
    Experimental eye research, 2019, Volume: 185

    Topics: Adrenergic alpha-2 Receptor Agonists; Anesthetics, Combined; Anesthetics, Dissociative; Animals; Bio

2019
Electroretinography in Labrador retrievers given ketamine-xylazine anesthesia.
    American journal of veterinary research, 1987, Volume: 48, Issue:9

    Topics: Animals; Dog Diseases; Dogs; Electroretinography; Female; Ketamine; Male; Photic Stimulation; Retina

1987